Drugs / autologous CD34-selected peripheral blood stem cells transplant
autologous CD34-selected peripheral blood stem cells transplant
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00692939 | Jun 2012 → Dec 2026 expected | Crohn disease | Paul Szabolcs | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous CD34-selected peripheral blood stem cells transplant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00692939 ↗ |
| Modality | Cell therapy | “infusion of autologous CD34-selected peripheral blood stem cells (PBSC)” NCT00692939 ↗ |